New York State Common Retirement Fund Coherus Bio Sciences, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 20,593 shares of CHRS stock, worth $23,887. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,593
Previous 111,178
81.48%
Holding current value
$23,887
Previous $116,000
75.86%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding CHRS
# of Institutions
133Shares Held
77.1MCall Options Held
40.7KPut Options Held
50.1K-
Black Rock Inc. New York, NY11.8MShares$13.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$13.1 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.4MShares$12.1 Million0.3% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$3.52 Million0.18% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.86MShares$3.31 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $90.2M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...